(19)
(11) EP 3 761 965 A1

(12)

(43) Date of publication:
13.01.2021 Bulletin 2021/02

(21) Application number: 18711270.1

(22) Date of filing: 08.03.2018
(51) International Patent Classification (IPC): 
A61K 9/20(2006.01)
 A61K 9/16(2006.01)
(86) International application number:
PCT/EP2018/055824
(87) International publication number:
WO 2019/170244 (12.09.2019 Gazette 2019/37)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(71) Applicants:
  • Pharmaceutical Oriented Services Ltd
    14452 Metamorfossi Attikis (GR)
  • Rontis Hellas S.A.
    151 25 Marousi Athens (GR)

(72) Inventors:
  • PANAGOPOULOS, Panagiotis
    14452 Metamorfossi Attikis (GR)
  • PANITSAS, Konstantinos-Emmanouil
    14452 Metamorfossi Attikis (GR)
  • KOMPOROZOS, Konstantinos
    14452 Metamorfossi Attikis (GR)
  • KANTAS, Dimosthenis
    14452 Metamorfossi Attikis (GR)
  • GEORGAKAKOU, Sofia
    14452 Metamorfossi Attikis (GR)
  • PARELI, Ioanna
    14452 Metamorfossi Attikis (GR)

(74) Representative: Hamm&Wittkopp Patentanwälte PartmbB 
Jungfernstieg 38
20354 Hamburg
20354 Hamburg (DE)

   


(54) TICAGRELOR-CONTAINING TABLET FORMULATION